Clinical trial
PolyArginine Treated vEiN grafTs (PATENT)
NCT00264706 · Lumen Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00264706 |
|---|---|
| Title | PolyArginine Treated vEiN grafTs (PATENT) |
| Official title | PolyArginine Treated vEiN grafTs (PATENT) |
| Lead sponsor | Lumen Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Saphenous Vein Graft Disease |
| Intervention type | Drug |
| Interventions | Nona-L-arginine |
| Enrollment | 25 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Dec 13, 2005 |
| Last update posted | Sep 8, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: